Biotech IPO: GenMark Diagnostics
SA Editor Mohit Manghnani submits:GenMark Diagnostics (GNMK), a California based molecular diagnostics company, is expected to price its IPO this week. Business Overview (from prospectus)Complete Story » seekingalpha.com |
Doctors Fight Cosmetic Foot Surgery
Toe shortening, toe lengthening and injections into the pads of the feet are among cosmetic foot procedures blasted by the American Orthopaedic Foot and Ankle Society. online.wsj.com |
Kendall Law Group Investigates Enzo Biochem Inc. for Shareholders (Business Wire)
DALLAS----Kendall Law Group, a national securities firm led by a former federal judge Joe Kendall with attorneys that include a former U.S. Attorney, is investigating Enzo Biochem Inc. for shareholders. us.rd.yahoo.com |
Bottom Fishing: Any Value in September's Losers?
StreetAuthority submits: by David StermanWith reward comes risk. That's the painful lesson learned by biotech investors last month. Investors in Arena Pharma (Nasdaq: ARNA), Idenix Pharma (Nasdaq: IDIX), AMAG Pharma (Nasdaq: AMAG) and Vical (Nasdaq: VICL) all saw their investments plunge by nearly a fourth-- or more -- thanks to bad news on the drug approval front. Of the top four losers in the Russell 2000 last month, all are in biotech -- an industry for which you've got to have a strong stomach.Complete Story » seekingalpha.com |
PPD Reports Third Quarter 2010 Financial Results
[Business Wire] - PPD, Inc. today reported its financial and operating results for the third quarter ended September 30, 2010. us.rd.yahoo.com |